doxorubicin hydrochloride in the United States
75 medicine records from 28 holders carry this name in the official sources. Collected on November 19, 2026.
Medicines
| Name | Holder | Code |
|---|---|---|
| DOXIL INJECTION, SUSPENSION, LIPOSOMAL | Baxter Healthcare Company |
Product NDC
0338-0063Package NDC
0338-0063-01
|
| DOXIL INJECTION, SUSPENSION, LIPOSOMAL | Baxter Healthcare Company |
Product NDC
0338-0067Package NDC
0338-0067-01
|
| DOXIL INJECTION, SUSPENSION, LIPOSOMAL | Baxter Healthcare Corporation |
Product NDC
0338-9665Package NDC
0338-9665-01
|
| DOXIL INJECTION, SUSPENSION, LIPOSOMAL | Baxter Healthcare Corporation |
Product NDC
0338-9667Package NDC
0338-9667-01
|
| Doxorubicin POWDER | Meiji Seika Pharma Co., Ltd. |
Product NDC
12543-3209Package NDC
12543-3209-2
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Pfizer Laboratories Div Pfizer Inc |
Product NDC
0069-0255Package NDC
0069-0255-10
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Pfizer Laboratories Div Pfizer Inc |
Product NDC
0069-0277Package NDC
0069-0277-02
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Pfizer Laboratories Div Pfizer Inc |
Product NDC
0069-0343Package NDC
0069-0343-02
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Pfizer Laboratories Div Pfizer Inc |
Product NDC
0069-0358Package NDC
0069-0358-20
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Pfizer Laboratories Div Pfizer Inc |
Product NDC
0069-1442Package NDC
0069-1442-04
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Pfizer Laboratories Div Pfizer Inc |
Product NDC
0069-1542Package NDC
0069-1542-20
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Pfizer Laboratories Div Pfizer Inc |
Product NDC
0069-3358Package NDC
0069-3358-25
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Pfizer Laboratories Div Pfizer Inc |
Product NDC
0069-4031Package NDC
0069-4031-12
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Pfizer Laboratories Div Pfizer Inc |
Product NDC
0069-4205Package NDC
0069-4205-05
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Pfizer Laboratories Div Pfizer Inc |
Product NDC
0069-5629Package NDC
0069-5629-05
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Hikma Pharmaceuticals USA Inc. |
Product NDC
0143-9084Package NDC
0143-9084-01
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Hikma Pharmaceuticals USA Inc. |
Product NDC
0143-9085Package NDC
0143-9085-01
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Hikma Pharmaceuticals USA Inc. |
Product NDC
0143-9086Package NDC
0143-9086-01
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Hikma Pharmaceuticals USA Inc. |
Product NDC
0143-9087Package NDC
0143-9087-01
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Hikma Pharmaceuticals USA Inc. |
Product NDC
0143-9088Package NDC
0143-9088-01
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Hikma Pharmaceuticals USA Inc. |
Product NDC
0143-9089Package NDC
0143-9089-01
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Hikma Pharmaceuticals USA Inc. |
Product NDC
0143-9090Package NDC
0143-9090-01
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Hikma Pharmaceuticals USA Inc. |
Product NDC
0143-9091Package NDC
0143-9091-01
|
| Doxorubicin Hydrochloride INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Hikma Pharmaceuticals USA Inc. |
Product NDC
0143-9092Package NDC
0143-9092-01
|
| Doxorubicin Hydrochloride INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Hikma Pharmaceuticals USA Inc. |
Product NDC
0143-9093Package NDC
0143-9093-01
|
| doxorubicin hydrochloride INJECTION, SUSPENSION, LIPOSOMAL | GlaxoSmithKline Manufacturing SpA |
Product NDC
12064-019Package NDC
12064-019-00
|
| Doxorubicin Hydrochloride POWDER | Olon SpA |
Product NDC
17337-0260Package NDC
17337-0260-1
|
| doxorubicin hydrochloride INJECTION, SOLUTION | Sagent Pharmaceuticals |
Product NDC
25021-207Package NDC
25021-207-25
|
| Doxorubicin hydrochloride INJECTION, SOLUTION | Actavis Pharma, Inc. |
Product NDC
45963-733Package NDC
45963-733-55
|
| doxorubicin hydrochloride INJECTION, SUSPENSION, LIPOSOMAL | Alembic Pharmaceuticals Limited |
Product NDC
46708-525Package NDC
46708-525-25
|
| doxorubicin hydrochloride INJECTION, SUSPENSION, LIPOSOMAL | Alembic Pharmaceuticals Limited |
Product NDC
46708-810Package NDC
46708-810-10
|
| Doxorubicin Hydrochloride INJECTABLE, LIPOSOMAL | Sun Pharmaceutical Industries, Inc. |
Product NDC
47335-049Package NDC
47335-049-40
|
| Doxorubicin Hydrochloride INJECTABLE, LIPOSOMAL | Sun Pharmaceutical Industries, Inc. |
Product NDC
47335-050Package NDC
47335-050-40
|
| DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL | Zydus Lifesciences Limited |
Product NDC
49315-008Package NDC
49315-008-03
|
| DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL | Zydus Lifesciences Limited |
Product NDC
49315-009Package NDC
49315-009-07
|
| Doxorubicin Hydrochloride POWDER | Sicor S.r.l. |
Product NDC
53183-7000Package NDC
53183-7000-1
|
| Doxorubicin Hydrochloride POWDER | MicroBiopharm Japan Co., Ltd. |
Product NDC
56161-101Package NDC
56161-101-01
|
| Doxorubicin Hydrochloride POWDER | Zhejiang Hisun Pharmaceutical Co., Ltd. |
Product NDC
58623-0029Package NDC
58623-0029-1
|
| Doxorubicin Hydrochloride POWDER | Zhejiang Hisun Pharmaceutical Co., Ltd. |
Product NDC
58623-0119Package NDC
58623-0119-1
|
| doxorubicin hydrochloride INJECTION, SUSPENSION, LIPOSOMAL | Alembic Pharmaceuticals Inc. |
Product NDC
62332-525Package NDC
62332-525-25
|
| doxorubicin hydrochloride INJECTION, SUSPENSION, LIPOSOMAL | Alembic Pharmaceuticals Inc. |
Product NDC
62332-810Package NDC
62332-810-10
|
| DOXOrubicin Hydrochloride INJECTION, SOLUTION | Sun Pharmaceutical Industries, Inc. |
Product NDC
62756-826Package NDC
62756-826-40
|
| DOXOrubicin Hydrochloride INJECTION, SOLUTION | Sun Pharmaceutical Industries, Inc. |
Product NDC
62756-827Package NDC
62756-827-40
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Fresenius Kabi USA, LLC |
Product NDC
63323-101Package NDC
63323-101-61
|
| Doxorubicin Hydrochloride INJECTION, SOLUTION | Fresenius Kabi USA, LLC |
Product NDC
63323-883Package NDC
63323-883-05
|
| doxorubicin hydrochloride INJECTION, SUSPENSION, LIPOSOMAL | Qilu Pharmaceutical Co., Ltd. |
Product NDC
67184-0623Package NDC
67184-0623-1
|
| doxorubicin hydrochloride INJECTION, SUSPENSION, LIPOSOMAL | Qilu Pharmaceutical Co., Ltd. |
Product NDC
67184-0624Package NDC
67184-0624-1
|
| Doxorubicin Hydrochloride INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | Mylan Institutional LLC |
Product NDC
67457-436Package NDC
67457-436-50
|
| Doxorubicin Hydrochloride INJECTABLE, LIPOSOMAL | BluePoint Laboratories |
Product NDC
68001-492Package NDC
68001-492-36
|
| Doxorubicin Hydrochloride INJECTABLE, LIPOSOMAL | BluePoint Laboratories |
Product NDC
68001-493Package NDC
68001-493-26
|
Need this list in your own system?
Every record on this page is available through the API, with its source, licence and retrieval date.